Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of presentations that were discussed at the AACR 2017 annual meeting. She describes the use of immune checkpoint blocking drugs in four different types of cancers: breast cancer, melanoma, merkel cell carcinoma, and lung cancer. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Use of Immune Checkpoint Blocking Drugs in Four Different Kinds of Cancers
